世界の性感染症（STD）診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Sexually Transmitted Disease (STD) Diagnosis Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5212
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、125ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、性感染症（STD）診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クラミジア検査、梅毒検査、淋病検査、単純ヘルペスウイルス検査、人間パピローマウイルス検査、人間免疫不全ウイルス検査）、用途別市場規模（政府機関、病院、診断クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・性感染症（STD）診断の市場動向
・企業の競争状況、市場シェア
・性感染症（STD）診断の種類別市場規模（クラミジア検査、梅毒検査、淋病検査、単純ヘルペスウイルス検査、人間パピローマウイルス検査、人間免疫不全ウイルス検査）
・性感染症（STD）診断の用途別市場規模（政府機関、病院、診断クリニック）
・性感染症（STD）診断の北米市場規模2016-2027（アメリカ、カナダ）
・性感染症（STD）診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・性感染症（STD）診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・性感染症（STD）診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・性感染症（STD）診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott、Roche、Thermo Fisher Scientific、Aposcience、BCR Diagnostics、BD Medical、Biocartis、BioMerieux、Bio-Rad、Cepheid、Danaher、DiaSorin、Quidel、GenMark Diagnostics、Hologic、OraSure Technologies、Qualigen）
・結論

Market Analysis and Insights: Global Sexually Transmitted Disease (STD) Diagnosis Market
The global Sexually Transmitted Disease (STD) Diagnosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sexually Transmitted Disease (STD) Diagnosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sexually Transmitted Disease (STD) Diagnosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sexually Transmitted Disease (STD) Diagnosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sexually Transmitted Disease (STD) Diagnosis market.

Global Sexually Transmitted Disease (STD) Diagnosis Scope and Market Size
Sexually Transmitted Disease (STD) Diagnosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sexually Transmitted Disease (STD) Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chlamydia testing
Syphilis testing
Gonorrhoea testing
Herpes simplex virus testing
Human papilloma virus testing
Human immunodeficiency virus testing

Segment by Application
Government organizations
Hospitals
Diagnostic clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Roche
Thermo Fisher Scientific
Aposcience
BCR Diagnostics
BD Medical
Biocartis
BioMerieux
Bio-Rad
Aposcience
BCR Diagnostics
DiaSorin
Quidel
GenMark Diagnostics
Hologic

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chlamydia testing
1.2.3 Syphilis testing
1.2.4 Gonorrhoea testing
1.2.5 Herpes simplex virus testing
1.2.6 Human papilloma virus testing
1.2.7 Human immunodeficiency virus testing
1.3 Market by Application
1.3.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Government organizations
1.3.3 Hospitals
1.3.4 Diagnostic clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Perspective (2016-2027)
2.2 Sexually Transmitted Disease (STD) Diagnosis Growth Trends by Regions
2.2.1 Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sexually Transmitted Disease (STD) Diagnosis Historic Market Share by Regions (2016-2021)
2.2.3 Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Regions (2022-2027)
2.3 Sexually Transmitted Disease (STD) Diagnosis Industry Dynamic
2.3.1 Sexually Transmitted Disease (STD) Diagnosis Market Trends
2.3.2 Sexually Transmitted Disease (STD) Diagnosis Market Drivers
2.3.3 Sexually Transmitted Disease (STD) Diagnosis Market Challenges
2.3.4 Sexually Transmitted Disease (STD) Diagnosis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue
3.1.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue (2016-2021)
3.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Players (2016-2021)
3.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sexually Transmitted Disease (STD) Diagnosis Revenue
3.4 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio
3.4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2020
3.5 Sexually Transmitted Disease (STD) Diagnosis Key Players Head office and Area Served
3.6 Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
3.7 Date of Enter into Sexually Transmitted Disease (STD) Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Type
4.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Type (2016-2021)
4.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2022-2027)

5 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Application
5.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Application (2016-2021)
5.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size (2016-2027)
6.2 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type
6.2.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021)
6.2.2 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2022-2027)
6.2.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2027)
6.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application
6.3.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2021)
6.3.2 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2022-2027)
6.3.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2027)
6.4 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country
6.4.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2016-2021)
6.4.2 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size (2016-2027)
7.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type
7.2.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021)
7.2.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2022-2027)
7.2.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2027)
7.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application
7.3.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2021)
7.3.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2022-2027)
7.3.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2027)
7.4 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country
7.4.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2016-2021)
7.4.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size (2016-2027)
8.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Type
8.2.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Application
8.3.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region
8.4.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size (2016-2027)
9.2 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type
9.2.1 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021)
9.2.2 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2022-2027)
9.2.3 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2027)
9.3 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application
9.3.1 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2021)
9.3.2 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2022-2027)
9.3.3 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2027)
9.4 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country
9.4.1 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2016-2021)
9.4.2 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size (2016-2027)
10.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Type
10.2.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Application
10.3.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country
10.4.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Introduction
11.1.4 Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Introduction
11.2.4 Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Introduction
11.3.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Aposcience
11.4.1 Aposcience Company Details
11.4.2 Aposcience Business Overview
11.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Introduction
11.4.4 Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.4.5 Aposcience Recent Development
11.5 BCR Diagnostics
11.5.1 BCR Diagnostics Company Details
11.5.2 BCR Diagnostics Business Overview
11.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
11.5.4 BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.5.5 BCR Diagnostics Recent Development
11.6 BD Medical
11.6.1 BD Medical Company Details
11.6.2 BD Medical Business Overview
11.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Introduction
11.6.4 BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.6.5 BD Medical Recent Development
11.7 Biocartis
11.7.1 Biocartis Company Details
11.7.2 Biocartis Business Overview
11.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Introduction
11.7.4 Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.7.5 Biocartis Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Details
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Introduction
11.8.4 BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.8.5 BioMerieux Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Introduction
11.9.4 Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.9.5 Bio-Rad Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Details
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Introduction
11.10.4 Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.10.5 Cepheid Recent Development
11.11 Danaher
11.11.1 Danaher Company Details
11.11.2 Danaher Business Overview
11.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Introduction
11.11.4 Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.11.5 Danaher Recent Development
11.12 DiaSorin
11.12.1 DiaSorin Company Details
11.12.2 DiaSorin Business Overview
11.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Introduction
11.12.4 DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.12.5 DiaSorin Recent Development
11.13 Quidel
11.13.1 Quidel Company Details
11.13.2 Quidel Business Overview
11.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Introduction
11.13.4 Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.13.5 Quidel Recent Development
11.14 GenMark Diagnostics
11.14.1 GenMark Diagnostics Company Details
11.14.2 GenMark Diagnostics Business Overview
11.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
11.14.4 GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.14.5 GenMark Diagnostics Recent Development
11.15 Hologic
11.15.1 Hologic Company Details
11.15.2 Hologic Business Overview
11.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Introduction
11.15.4 Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.15.5 Hologic Recent Development
11.16 OraSure Technologies
11.16.1 OraSure Technologies Company Details
11.16.2 OraSure Technologies Business Overview
11.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Introduction
11.16.4 OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.16.5 OraSure Technologies Recent Development
11.17 Qualigen
11.17.1 Qualigen Company Details
11.17.2 Qualigen Business Overview
11.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Introduction
11.17.4 Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
11.17.5 Qualigen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chlamydia testing
Table 3. Key Players of Syphilis testing
Table 4. Key Players of Gonorrhoea testing
Table 5. Key Players of Herpes simplex virus testing
Table 6. Key Players of Human papilloma virus testing
Table 7. Key Players of Human immunodeficiency virus testing
Table 8. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Regions (2016-2021)
Table 12. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Regions (2022-2027)
Table 14. Sexually Transmitted Disease (STD) Diagnosis Market Trends
Table 15. Sexually Transmitted Disease (STD) Diagnosis Market Drivers
Table 16. Sexually Transmitted Disease (STD) Diagnosis Market Challenges
Table 17. Sexually Transmitted Disease (STD) Diagnosis Market Restraints
Table 18. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players (2016-2021)
Table 20. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2020)
Table 21. Ranking of Global Top Sexually Transmitted Disease (STD) Diagnosis Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
Table 25. Date of Enter into Sexually Transmitted Disease (STD) Diagnosis Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2016-2021)
Table 29. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2016-2021)
Table 33. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 65. Abbott Company Details
Table 66. Abbott Business Overview
Table 67. Abbott Sexually Transmitted Disease (STD) Diagnosis Product
Table 68. Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 69. Abbott Recent Development
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Sexually Transmitted Disease (STD) Diagnosis Product
Table 73. Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 74. Roche Recent Development
Table 75. Thermo Fisher Scientific Company Details
Table 76. Thermo Fisher Scientific Business Overview
Table 77. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product
Table 78. Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 79. Thermo Fisher Scientific Recent Development
Table 80. Aposcience Company Details
Table 81. Aposcience Business Overview
Table 82. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product
Table 83. Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 84. Aposcience Recent Development
Table 85. BCR Diagnostics Company Details
Table 86. BCR Diagnostics Business Overview
Table 87. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product
Table 88. BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 89. BCR Diagnostics Recent Development
Table 90. BD Medical Company Details
Table 91. BD Medical Business Overview
Table 92. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product
Table 93. BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 94. BD Medical Recent Development
Table 95. Biocartis Company Details
Table 96. Biocartis Business Overview
Table 97. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product
Table 98. Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 99. Biocartis Recent Development
Table 100. BioMerieux Company Details
Table 101. BioMerieux Business Overview
Table 102. BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 103. BioMerieux Recent Development
Table 104. Bio-Rad Company Details
Table 105. Bio-Rad Business Overview
Table 106. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product
Table 107. Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 108. Bio-Rad Recent Development
Table 109. Cepheid Company Details
Table 110. Cepheid Business Overview
Table 111. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product
Table 112. Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 113. Cepheid Recent Development
Table 114. Danaher Company Details
Table 115. Danaher Business Overview
Table 116. Danaher Sexually Transmitted Disease (STD) Diagnosis Product
Table 117. Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 118. Danaher Recent Development
Table 119. DiaSorin Company Details
Table 120. DiaSorin Business Overview
Table 121. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product
Table 122. DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 123. DiaSorin Recent Development
Table 124. Quidel Company Details
Table 125. Quidel Business Overview
Table 126. Quidel Sexually Transmitted Disease (STD) Diagnosis Product
Table 127. Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 128. Quidel Recent Development
Table 129. GenMark Diagnostics Company Details
Table 130. GenMark Diagnostics Business Overview
Table 131. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product
Table 132. GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 133. GenMark Diagnostics Recent Development
Table 134. Hologic Company Details
Table 135. Hologic Business Overview
Table 136. Hologic Sexually Transmitted Disease (STD) Diagnosis Product
Table 137. Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 138. Hologic Recent Development
Table 139. OraSure Technologies Company Details
Table 140. OraSure Technologies Business Overview
Table 141. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product
Table 142. OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 143. OraSure Technologies Recent Development
Table 144. Qualigen Company Details
Table 145. Qualigen Business Overview
Table 146. Qualigen Sexually Transmitted Disease (STD) Diagnosis Product
Table 147. Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021) & (US$ Million)
Table 148. Qualigen Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Type: 2020 VS 2027
Figure 2. Chlamydia testing Features
Figure 3. Syphilis testing Features
Figure 4. Gonorrhoea testing Features
Figure 5. Herpes simplex virus testing Features
Figure 6. Human papilloma virus testing Features
Figure 7. Human immunodeficiency virus testing Features
Figure 8. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Application: 2020 VS 2027
Figure 9. Government organizations Case Studies
Figure 10. Hospitals Case Studies
Figure 11. Diagnostic clinics Case Studies
Figure 12. Sexually Transmitted Disease (STD) Diagnosis Report Years Considered
Figure 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Sexually Transmitted Disease (STD) Diagnosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Regions: 2020 VS 2027
Figure 16. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Regions (2022-2027)
Figure 17. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players in 2020
Figure 18. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2020
Figure 20. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2016-2021)
Figure 21. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2022-2027)
Figure 22. North America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2016-2027)
Figure 24. North America Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2016-2027)
Figure 25. North America Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2016-2027)
Figure 26. United States Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2016-2027)
Figure 30. Europe Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2016-2027)
Figure 31. Europe Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2016-2027)
Figure 32. Germany Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2016-2027)
Figure 42. China Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2016-2027)
Figure 50. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2016-2027)
Figure 51. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2016-2027)
Figure 52. Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2016-2027)
Figure 58. Turkey Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 64. Aposcience Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 65. BCR Diagnostics Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 66. BD Medical Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 67. Biocartis Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 68. BioMerieux Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 69. Bio-Rad Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 70. Cepheid Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 71. Danaher Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 72. DiaSorin Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 73. Quidel Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 74. GenMark Diagnostics Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 75. Hologic Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 76. OraSure Technologies Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 77. Qualigen Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

以下、関連資料のご紹介

世界の肝炎検査用溶液/診断市場規模・現状・予測（2021年-2027年）

Global Hepatitis Test Solution/Diagnosis Market Size, Status and Forecast 2021-2027
QYR2104Z2797 2021年4月 92Pages
QYResearch社発行の本調査資料では、肝炎検査用溶液/診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B型肝炎、HCV、HAV、HDV、その他）、用途別市場規模（病院・診断研究所、血液バンク、その他）、主要地域別市場規模（北米、アメリ...

世界の顧みられない熱帯病（NTD）診断市場規模・現状・予測（2021年-2027年）

Global Neglected Tropical Diseases Diagnosis Market Size, Status and Forecast 2021-2027
QYR2104Z4052 2021年4月 95Pages
QYResearch社発行の本調査資料では、顧みられない熱帯病（NTD）診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（従来方式、分子/現代方式）、用途別市場規模（クリニックラボ、病院/クリニック、在宅医療）、主要地域別市場規模（北米、アメ...

世界のコンピュータ支援検出・診断市場規模・現状・予測（2021年-2027年）

Global Computer-aided Detection and Diagnosis Market Size, Status and Forecast 2021-2027
QYR2104Z1525 2021年4月 90Pages
QYResearch社発行の本調査資料では、コンピュータ支援検出・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（X線画像、コンピュータ断層撮影、超音波画像、磁気共鳴画像、核医学画像、その他）、用途別市場規模（乳がん、肺がん、結腸直腸がん、...

世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年）

Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z0275 2021年4月 91Pages
QYResearch社発行の本調査資料では、アルツハイマー病治療・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腰椎穿刺検査、コンピューター断層撮影（CT）スキャン、磁気共鳴画像（MRI）、脳波（EEG）、ポジトロン放出断層撮影（PET）...

世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年）

Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z0278 2021年4月 91Pages
QYResearch社発行の本調査資料では、アルツハイマー病治療・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体拮抗薬、脳イメージング、血液検査）、用途別市場規模（医薬品市場、診断市...

世界の感染症検査・診断市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Testing And Diagnostic Market Size, Status and Forecast 2021-2027
QYR2104Z3144 2021年4月 94Pages
QYResearch社発行の本調査資料では、感染症検査・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫診断、臨床微生物学、ポリメラーゼ連鎖反応、次世代シーケンシング、その他）、用途別市場規模（病院・臨床研究所、学術・研究所、参照研究所...

世界の感染症検査・診断市場規模・現状・予測（2021年-2027年）

世界の呼吸器疾患検査/診断市場規模・現状・予測（2021年-2027年）

Global Respiratory Disease Testing/Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z5002 2021年4月 131Pages
QYResearch社発行の本調査資料では、呼吸器疾患検査/診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（画像検査、呼吸測定、血液ガス検査、その他）、用途別市場規模（病院、医師クリニック、臨床検査室、その他）、主要地域別市場規模（北米、ア...

世界の自己免疫疾患診断市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disease Diagnosis Market Size, Status and Forecast 2021-2027
QYR2104Z0518 2021年4月 98Pages
QYResearch社発行の本調査資料では、自己免疫疾患診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（定期検査、炎症マーカー、自己抗体・免疫学的検査、その他検査）、用途別市場規模（臨床検査室、病院、その他エンドユーザー）、主要地域別市場規...

世界の呼吸器合胞体ウイルス（RSV）診断市場規模・現状・予測（2021年-2027年）

Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z5008 2021年4月 92Pages
QYResearch社発行の本調査資料では、呼吸器合胞体ウイルス（RSV）診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（分子診断、迅速抗原検査、その他）、用途別市場規模（病院、診療所、検査室、その他）、主要地域別市場規模（北米、アメリカ、...

世界のヒトパピローマウイルス検査市場規模・現状・予測（2021年-2027年） HPV testing and Pap test market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test. The increasing incidence rate of cervical and vaginal cancer is the key driver for the market growth. Market Analysis and Insights: Global Human papilloma virus Testing M…
世界のヒトパピローマウイルス検査市場規模・現状・予測（2021年-2027年） HPV testing and Pap test market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test. The increasing incidence rate of cervical and vaginal cancer is the key driver for the market growth. Market Analysis and Insights: Global Human papilloma virus Testing M…
世界のヒト免疫不全ウイルス検査市場規模・現状・予測（2021年-2027年） Human Immunodeficiency Virus Testing is the procedure to test if the patient have the Human Immunodeficiency Virus Market Analysis and Insights: Global Human Immunodeficiency Virus Testing Market The global Human Immunodeficiency Virus Testing market size is projected to reach US$ XX million by 2026…
世界の単純ヘルペスウイルス検査市場規模・現状・予測（2021年-2027年） Herpes Simplex Virus Testing is the procedure to test if the patient have the Herpes Simplex Virus Market Analysis and Insights: Global Herpes Simplex Virus Testing Market The global Herpes Simplex Virus Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, a…
世界のC型肝炎ウイルス検査市場規模・現状・予測（2021年-2027年） Hepatitis C virus (HCV) infection is detected with a blood test. Market Analysis and Insights: Global Hepatitis C Virus Testing Market The global Hepatitis C Virus Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With i…